nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenoldopam—Transaminases increased—Alendronate—osteoporosis	0.0143	0.0201	CcSEcCtD
Fenoldopam—Myocardial ischaemia—Ibandronate—osteoporosis	0.0105	0.0148	CcSEcCtD
Fenoldopam—Creatinine increased—Ibandronate—osteoporosis	0.00891	0.0125	CcSEcCtD
Fenoldopam—Injection site reaction—Ibandronate—osteoporosis	0.00843	0.0119	CcSEcCtD
Fenoldopam—Bradycardia—Calcium Acetate—osteoporosis	0.00796	0.0112	CcSEcCtD
Fenoldopam—Blood urea increased—Calcitriol—osteoporosis	0.00784	0.011	CcSEcCtD
Fenoldopam—Oliguria—Conjugated Estrogens—osteoporosis	0.00634	0.00891	CcSEcCtD
Fenoldopam—Blood urea increased—Pamidronate—osteoporosis	0.00627	0.00882	CcSEcCtD
Fenoldopam—Creatinine increased—Conjugated Estrogens—osteoporosis	0.00614	0.00863	CcSEcCtD
Fenoldopam—Injection site reaction—Zoledronate—osteoporosis	0.00603	0.00848	CcSEcCtD
Fenoldopam—Myocardial ischaemia—Estradiol—osteoporosis	0.00582	0.00818	CcSEcCtD
Fenoldopam—Blood creatinine increased—Ibandronate—osteoporosis	0.00577	0.00811	CcSEcCtD
Fenoldopam—Blood urea increased—Zoledronate—osteoporosis	0.00573	0.00805	CcSEcCtD
Fenoldopam—Blood creatinine increased—Calcitriol—osteoporosis	0.00564	0.00794	CcSEcCtD
Fenoldopam—Blood urea increased—Conjugated Estrogens—osteoporosis	0.00552	0.00776	CcSEcCtD
Fenoldopam—Hypotension—Calcium Acetate—osteoporosis	0.00519	0.0073	CcSEcCtD
Fenoldopam—Cardiac failure—Pamidronate—osteoporosis	0.00494	0.00695	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Estropipate—osteoporosis	0.00488	0.00686	CcSEcCtD
Fenoldopam—Myocardial infarction—Estropipate—osteoporosis	0.00485	0.00682	CcSEcCtD
Fenoldopam—Constipation—Calcium Acetate—osteoporosis	0.00475	0.00668	CcSEcCtD
Fenoldopam—Urinary tract infection—Raloxifene—osteoporosis	0.00466	0.00655	CcSEcCtD
Fenoldopam—Urinary tract infection—Ibandronate—osteoporosis	0.00461	0.00648	CcSEcCtD
Fenoldopam—Sweating—Raloxifene—osteoporosis	0.00459	0.00646	CcSEcCtD
Fenoldopam—Sweating—Ibandronate—osteoporosis	0.00455	0.00639	CcSEcCtD
Fenoldopam—Blood creatinine increased—Pamidronate—osteoporosis	0.00452	0.00635	CcSEcCtD
Fenoldopam—Urinary tract infection—Calcitriol—osteoporosis	0.00451	0.00635	CcSEcCtD
Fenoldopam—Haemoglobin—Alendronate—osteoporosis	0.0044	0.00618	CcSEcCtD
Fenoldopam—Hypokalaemia—Pamidronate—osteoporosis	0.00439	0.00617	CcSEcCtD
Fenoldopam—Haemorrhage—Alendronate—osteoporosis	0.00437	0.00615	CcSEcCtD
Fenoldopam—Muscle spasms—Etidronic acid—osteoporosis	0.0043	0.00604	CcSEcCtD
Fenoldopam—Haemoglobin—Ibandronate—osteoporosis	0.00428	0.00602	CcSEcCtD
Fenoldopam—Angina pectoris—Risedronate—osteoporosis	0.00427	0.006	CcSEcCtD
Fenoldopam—Haemorrhage—Ibandronate—osteoporosis	0.00426	0.00599	CcSEcCtD
Fenoldopam—Constipation—Ergocalciferol—osteoporosis	0.0042	0.0059	CcSEcCtD
Fenoldopam—Haemoglobin—Calcitriol—osteoporosis	0.00419	0.00589	CcSEcCtD
Fenoldopam—Haemorrhage—Calcitriol—osteoporosis	0.00417	0.00586	CcSEcCtD
Fenoldopam—Blood creatinine increased—Zoledronate—osteoporosis	0.00413	0.0058	CcSEcCtD
Fenoldopam—Hypokalaemia—Zoledronate—osteoporosis	0.00401	0.00564	CcSEcCtD
Fenoldopam—Flushing—Raloxifene—osteoporosis	0.00399	0.00561	CcSEcCtD
Fenoldopam—Blood creatinine increased—Conjugated Estrogens—osteoporosis	0.00397	0.00559	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Ethinyl Estradiol—osteoporosis	0.00395	0.00556	CcSEcCtD
Fenoldopam—Myocardial infarction—Ethinyl Estradiol—osteoporosis	0.00393	0.00553	CcSEcCtD
Fenoldopam—Urinary tract infection—Ethinyl Estradiol—osteoporosis	0.0039	0.00548	CcSEcCtD
Fenoldopam—Hypokalaemia—Conjugated Estrogens—osteoporosis	0.00386	0.00543	CcSEcCtD
Fenoldopam—Diarrhoea—Calcium Acetate—osteoporosis	0.0038	0.00534	CcSEcCtD
Fenoldopam—Urinary tract infection—Risedronate—osteoporosis	0.0038	0.00534	CcSEcCtD
Fenoldopam—Tension—Estropipate—osteoporosis	0.00379	0.00533	CcSEcCtD
Fenoldopam—Nervousness—Estropipate—osteoporosis	0.00375	0.00528	CcSEcCtD
Fenoldopam—Back pain—Estropipate—osteoporosis	0.00374	0.00526	CcSEcCtD
Fenoldopam—Nasal congestion—Estradiol—osteoporosis	0.00373	0.00524	CcSEcCtD
Fenoldopam—Muscle spasms—Estropipate—osteoporosis	0.00372	0.00523	CcSEcCtD
Fenoldopam—Dizziness—Calcium Acetate—osteoporosis	0.00367	0.00516	CcSEcCtD
Fenoldopam—Muscle spasms—Alendronate—osteoporosis	0.00366	0.00515	CcSEcCtD
Fenoldopam—Haemoglobin—Ethinyl Estradiol—osteoporosis	0.00362	0.00509	CcSEcCtD
Fenoldopam—Urinary tract infection—Pamidronate—osteoporosis	0.00361	0.00508	CcSEcCtD
Fenoldopam—Muscle spasms—Raloxifene—osteoporosis	0.0036	0.00506	CcSEcCtD
Fenoldopam—Haemorrhage—Ethinyl Estradiol—osteoporosis	0.0036	0.00506	CcSEcCtD
Fenoldopam—Back pain—Ibandronate—osteoporosis	0.00359	0.00504	CcSEcCtD
Fenoldopam—Muscle spasms—Ibandronate—osteoporosis	0.00356	0.00501	CcSEcCtD
Fenoldopam—Vomiting—Calcium Acetate—osteoporosis	0.00353	0.00497	CcSEcCtD
Fenoldopam—Haemoglobin—Risedronate—osteoporosis	0.00353	0.00496	CcSEcCtD
Fenoldopam—Haemorrhage—Risedronate—osteoporosis	0.00351	0.00493	CcSEcCtD
Fenoldopam—Palpitations—Estropipate—osteoporosis	0.00342	0.0048	CcSEcCtD
Fenoldopam—Haemoglobin—Pamidronate—osteoporosis	0.00335	0.00471	CcSEcCtD
Fenoldopam—Haemorrhage—Pamidronate—osteoporosis	0.00334	0.00469	CcSEcCtD
Fenoldopam—Urinary tract infection—Zoledronate—osteoporosis	0.0033	0.00464	CcSEcCtD
Fenoldopam—Nausea—Calcium Acetate—osteoporosis	0.0033	0.00464	CcSEcCtD
Fenoldopam—Anxiety—Estropipate—osteoporosis	0.00328	0.00461	CcSEcCtD
Fenoldopam—Palpitations—Ibandronate—osteoporosis	0.00328	0.00461	CcSEcCtD
Fenoldopam—Chest pain—Alendronate—osteoporosis	0.00324	0.00456	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Conjugated Estrogens—osteoporosis	0.00322	0.00453	CcSEcCtD
Fenoldopam—Myocardial infarction—Conjugated Estrogens—osteoporosis	0.0032	0.0045	CcSEcCtD
Fenoldopam—Chest pain—Raloxifene—osteoporosis	0.00319	0.00448	CcSEcCtD
Fenoldopam—Chest pain—Ibandronate—osteoporosis	0.00316	0.00444	CcSEcCtD
Fenoldopam—Anxiety—Ibandronate—osteoporosis	0.00314	0.00442	CcSEcCtD
Fenoldopam—Constipation—Etidronic acid—osteoporosis	0.00312	0.00438	CcSEcCtD
Fenoldopam—Bradycardia—Zoledronate—osteoporosis	0.0031	0.00436	CcSEcCtD
Fenoldopam—Flushing—Pamidronate—osteoporosis	0.0031	0.00435	CcSEcCtD
Fenoldopam—Chest pain—Calcitriol—osteoporosis	0.00309	0.00434	CcSEcCtD
Fenoldopam—Anxiety—Calcitriol—osteoporosis	0.00308	0.00433	CcSEcCtD
Fenoldopam—Back pain—Ethinyl Estradiol—osteoporosis	0.00303	0.00426	CcSEcCtD
Fenoldopam—Muscle spasms—Ethinyl Estradiol—osteoporosis	0.00301	0.00424	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Etidronic acid—osteoporosis	0.00298	0.00419	CcSEcCtD
Fenoldopam—Back pain—Risedronate—osteoporosis	0.00295	0.00415	CcSEcCtD
Fenoldopam—Hyperhidrosis—Raloxifene—osteoporosis	0.00295	0.00415	CcSEcCtD
Fenoldopam—Muscle spasms—Risedronate—osteoporosis	0.00294	0.00413	CcSEcCtD
Fenoldopam—Hyperhidrosis—Ibandronate—osteoporosis	0.00292	0.00411	CcSEcCtD
Fenoldopam—Nausea—Ergocalciferol—osteoporosis	0.00291	0.0041	CcSEcCtD
Fenoldopam—Abdominal pain—Etidronic acid—osteoporosis	0.00288	0.00405	CcSEcCtD
Fenoldopam—Insomnia—Estropipate—osteoporosis	0.00285	0.00401	CcSEcCtD
Fenoldopam—Tension—Pamidronate—osteoporosis	0.00285	0.00401	CcSEcCtD
Fenoldopam—Flushing—Zoledronate—osteoporosis	0.00283	0.00398	CcSEcCtD
Fenoldopam—Nervousness—Pamidronate—osteoporosis	0.00282	0.00397	CcSEcCtD
Fenoldopam—Back pain—Pamidronate—osteoporosis	0.00281	0.00395	CcSEcCtD
Fenoldopam—Muscle spasms—Pamidronate—osteoporosis	0.00279	0.00393	CcSEcCtD
Fenoldopam—Insomnia—Raloxifene—osteoporosis	0.00276	0.00389	CcSEcCtD
Fenoldopam—Insomnia—Ibandronate—osteoporosis	0.00274	0.00385	CcSEcCtD
Fenoldopam—Constipation—Estropipate—osteoporosis	0.0027	0.00379	CcSEcCtD
Fenoldopam—Insomnia—Calcitriol—osteoporosis	0.00268	0.00377	CcSEcCtD
Fenoldopam—Anxiety—Ethinyl Estradiol—osteoporosis	0.00266	0.00374	CcSEcCtD
Fenoldopam—Constipation—Alendronate—osteoporosis	0.00266	0.00374	CcSEcCtD
Fenoldopam—Chest pain—Risedronate—osteoporosis	0.0026	0.00366	CcSEcCtD
Fenoldopam—Anxiety—Risedronate—osteoporosis	0.00259	0.00364	CcSEcCtD
Fenoldopam—Constipation—Ibandronate—osteoporosis	0.00259	0.00364	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Estropipate—osteoporosis	0.00258	0.00363	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Estradiol—osteoporosis	0.00258	0.00363	CcSEcCtD
Fenoldopam—Back pain—Zoledronate—osteoporosis	0.00257	0.00361	CcSEcCtD
Fenoldopam—Myocardial infarction—Estradiol—osteoporosis	0.00256	0.00361	CcSEcCtD
Fenoldopam—Muscle spasms—Zoledronate—osteoporosis	0.00255	0.00359	CcSEcCtD
Fenoldopam—Urinary tract infection—Estradiol—osteoporosis	0.00254	0.00358	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Alendronate—osteoporosis	0.00254	0.00357	CcSEcCtD
Fenoldopam—Constipation—Calcitriol—osteoporosis	0.00253	0.00356	CcSEcCtD
Fenoldopam—Tension—Conjugated Estrogens—osteoporosis	0.00251	0.00352	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Raloxifene—osteoporosis	0.0025	0.00351	CcSEcCtD
Fenoldopam—Diarrhoea—Etidronic acid—osteoporosis	0.00249	0.00351	CcSEcCtD
Fenoldopam—Abdominal pain—Estropipate—osteoporosis	0.00249	0.00351	CcSEcCtD
Fenoldopam—Body temperature increased—Estropipate—osteoporosis	0.00249	0.00351	CcSEcCtD
Fenoldopam—Nervousness—Conjugated Estrogens—osteoporosis	0.00248	0.00349	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Ibandronate—osteoporosis	0.00247	0.00348	CcSEcCtD
Fenoldopam—Back pain—Conjugated Estrogens—osteoporosis	0.00247	0.00347	CcSEcCtD
Fenoldopam—Anxiety—Pamidronate—osteoporosis	0.00246	0.00346	CcSEcCtD
Fenoldopam—Body temperature increased—Alendronate—osteoporosis	0.00246	0.00345	CcSEcCtD
Fenoldopam—Abdominal pain—Alendronate—osteoporosis	0.00246	0.00345	CcSEcCtD
Fenoldopam—Muscle spasms—Conjugated Estrogens—osteoporosis	0.00246	0.00345	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Calcitriol—osteoporosis	0.00242	0.00341	CcSEcCtD
Fenoldopam—Abdominal pain—Raloxifene—osteoporosis	0.00242	0.0034	CcSEcCtD
Fenoldopam—Body temperature increased—Raloxifene—osteoporosis	0.00242	0.0034	CcSEcCtD
Fenoldopam—Abdominal pain—Ibandronate—osteoporosis	0.00239	0.00336	CcSEcCtD
Fenoldopam—Body temperature increased—Ibandronate—osteoporosis	0.00239	0.00336	CcSEcCtD
Fenoldopam—Haemoglobin—Estradiol—osteoporosis	0.00236	0.00332	CcSEcCtD
Fenoldopam—Haemorrhage—Estradiol—osteoporosis	0.00235	0.0033	CcSEcCtD
Fenoldopam—Palpitations—Zoledronate—osteoporosis	0.00234	0.0033	CcSEcCtD
Fenoldopam—Body temperature increased—Calcitriol—osteoporosis	0.00234	0.00329	CcSEcCtD
Fenoldopam—Abdominal pain—Calcitriol—osteoporosis	0.00234	0.00329	CcSEcCtD
Fenoldopam—Vomiting—Etidronic acid—osteoporosis	0.00232	0.00326	CcSEcCtD
Fenoldopam—Tachycardia—Pamidronate—osteoporosis	0.00231	0.00325	CcSEcCtD
Fenoldopam—Hyperhidrosis—Pamidronate—osteoporosis	0.00229	0.00322	CcSEcCtD
Fenoldopam—Headache—Etidronic acid—osteoporosis	0.00228	0.00321	CcSEcCtD
Fenoldopam—Chest pain—Zoledronate—osteoporosis	0.00226	0.00318	CcSEcCtD
Fenoldopam—Palpitations—Conjugated Estrogens—osteoporosis	0.00226	0.00317	CcSEcCtD
Fenoldopam—Insomnia—Risedronate—osteoporosis	0.00225	0.00317	CcSEcCtD
Fenoldopam—Anxiety—Zoledronate—osteoporosis	0.00225	0.00316	CcSEcCtD
Fenoldopam—Dyspnoea—Risedronate—osteoporosis	0.00222	0.00313	CcSEcCtD
Fenoldopam—Hypotension—Pamidronate—osteoporosis	0.00221	0.00311	CcSEcCtD
Fenoldopam—Constipation—Ethinyl Estradiol—osteoporosis	0.00219	0.00307	CcSEcCtD
Fenoldopam—Flushing—Estradiol—osteoporosis	0.00218	0.00306	CcSEcCtD
Fenoldopam—Chest pain—Conjugated Estrogens—osteoporosis	0.00217	0.00306	CcSEcCtD
Fenoldopam—Anxiety—Conjugated Estrogens—osteoporosis	0.00217	0.00305	CcSEcCtD
Fenoldopam—Nausea—Etidronic acid—osteoporosis	0.00217	0.00305	CcSEcCtD
Fenoldopam—Diarrhoea—Estropipate—osteoporosis	0.00216	0.00304	CcSEcCtD
Fenoldopam—Insomnia—Pamidronate—osteoporosis	0.00214	0.00301	CcSEcCtD
Fenoldopam—Constipation—Risedronate—osteoporosis	0.00213	0.003	CcSEcCtD
Fenoldopam—Diarrhoea—Alendronate—osteoporosis	0.00213	0.00299	CcSEcCtD
Fenoldopam—Dyspnoea—Pamidronate—osteoporosis	0.00211	0.00297	CcSEcCtD
Fenoldopam—Tachycardia—Zoledronate—osteoporosis	0.00211	0.00297	CcSEcCtD
Fenoldopam—Hyperhidrosis—Zoledronate—osteoporosis	0.00209	0.00294	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.00209	0.00294	CcSEcCtD
Fenoldopam—Diarrhoea—Raloxifene—osteoporosis	0.00209	0.00294	CcSEcCtD
Fenoldopam—Dizziness—Estropipate—osteoporosis	0.00209	0.00293	CcSEcCtD
Fenoldopam—Diarrhoea—Ibandronate—osteoporosis	0.00207	0.00291	CcSEcCtD
Fenoldopam—Dizziness—Alendronate—osteoporosis	0.00205	0.00289	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Risedronate—osteoporosis	0.00204	0.00287	CcSEcCtD
Fenoldopam—Tachycardia—Conjugated Estrogens—osteoporosis	0.00203	0.00286	CcSEcCtD
Fenoldopam—Constipation—Pamidronate—osteoporosis	0.00203	0.00285	CcSEcCtD
Fenoldopam—Diarrhoea—Calcitriol—osteoporosis	0.00203	0.00285	CcSEcCtD
Fenoldopam—Hypotension—Zoledronate—osteoporosis	0.00202	0.00284	CcSEcCtD
Fenoldopam—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00202	0.00284	CcSEcCtD
Fenoldopam—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00202	0.00284	CcSEcCtD
Fenoldopam—Dizziness—Raloxifene—osteoporosis	0.00202	0.00284	CcSEcCtD
Fenoldopam—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.00201	0.00283	CcSEcCtD
Fenoldopam—Tension—Estradiol—osteoporosis	0.00201	0.00282	CcSEcCtD
Fenoldopam—Vomiting—Estropipate—osteoporosis	0.00201	0.00282	CcSEcCtD
Fenoldopam—Dizziness—Ibandronate—osteoporosis	0.002	0.00281	CcSEcCtD
Fenoldopam—Nervousness—Estradiol—osteoporosis	0.00199	0.00279	CcSEcCtD
Fenoldopam—Back pain—Estradiol—osteoporosis	0.00198	0.00278	CcSEcCtD
Fenoldopam—Headache—Estropipate—osteoporosis	0.00198	0.00278	CcSEcCtD
Fenoldopam—Vomiting—Alendronate—osteoporosis	0.00198	0.00278	CcSEcCtD
Fenoldopam—Abdominal pain—Risedronate—osteoporosis	0.00197	0.00277	CcSEcCtD
Fenoldopam—Body temperature increased—Risedronate—osteoporosis	0.00197	0.00277	CcSEcCtD
Fenoldopam—Muscle spasms—Estradiol—osteoporosis	0.00197	0.00276	CcSEcCtD
Fenoldopam—Insomnia—Zoledronate—osteoporosis	0.00196	0.00275	CcSEcCtD
Fenoldopam—Hypotension—Conjugated Estrogens—osteoporosis	0.00195	0.00274	CcSEcCtD
Fenoldopam—Headache—Alendronate—osteoporosis	0.00195	0.00274	CcSEcCtD
Fenoldopam—Vomiting—Raloxifene—osteoporosis	0.00194	0.00273	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Pamidronate—osteoporosis	0.00194	0.00273	CcSEcCtD
Fenoldopam—Dyspnoea—Zoledronate—osteoporosis	0.00193	0.00271	CcSEcCtD
Fenoldopam—Vomiting—Ibandronate—osteoporosis	0.00192	0.0027	CcSEcCtD
Fenoldopam—Headache—Raloxifene—osteoporosis	0.00191	0.00269	CcSEcCtD
Fenoldopam—Headache—Ibandronate—osteoporosis	0.00189	0.00266	CcSEcCtD
Fenoldopam—Insomnia—Conjugated Estrogens—osteoporosis	0.00189	0.00265	CcSEcCtD
Fenoldopam—Vomiting—Calcitriol—osteoporosis	0.00188	0.00265	CcSEcCtD
Fenoldopam—Nausea—Estropipate—osteoporosis	0.00187	0.00263	CcSEcCtD
Fenoldopam—Abdominal pain—Pamidronate—osteoporosis	0.00187	0.00263	CcSEcCtD
Fenoldopam—Body temperature increased—Pamidronate—osteoporosis	0.00187	0.00263	CcSEcCtD
Fenoldopam—Dyspnoea—Conjugated Estrogens—osteoporosis	0.00186	0.00261	CcSEcCtD
Fenoldopam—Headache—Calcitriol—osteoporosis	0.00185	0.00261	CcSEcCtD
Fenoldopam—Constipation—Zoledronate—osteoporosis	0.00185	0.0026	CcSEcCtD
Fenoldopam—Nausea—Alendronate—osteoporosis	0.00185	0.0026	CcSEcCtD
Fenoldopam—Nausea—Raloxifene—osteoporosis	0.00181	0.00255	CcSEcCtD
Fenoldopam—Palpitations—Estradiol—osteoporosis	0.00181	0.00254	CcSEcCtD
Fenoldopam—Nausea—Ibandronate—osteoporosis	0.0018	0.00253	CcSEcCtD
Fenoldopam—Constipation—Conjugated Estrogens—osteoporosis	0.00178	0.00251	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Zoledronate—osteoporosis	0.00177	0.00249	CcSEcCtD
Fenoldopam—Nausea—Calcitriol—osteoporosis	0.00176	0.00247	CcSEcCtD
Fenoldopam—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.00175	0.00246	CcSEcCtD
Fenoldopam—Chest pain—Estradiol—osteoporosis	0.00174	0.00245	CcSEcCtD
Fenoldopam—Anxiety—Estradiol—osteoporosis	0.00173	0.00244	CcSEcCtD
Fenoldopam—Abdominal pain—Zoledronate—osteoporosis	0.00171	0.00241	CcSEcCtD
Fenoldopam—Body temperature increased—Zoledronate—osteoporosis	0.00171	0.00241	CcSEcCtD
Fenoldopam—Diarrhoea—Risedronate—osteoporosis	0.00171	0.0024	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.0017	0.0024	CcSEcCtD
Fenoldopam—Dizziness—Ethinyl Estradiol—osteoporosis	0.00169	0.00238	CcSEcCtD
Fenoldopam—Dizziness—Risedronate—osteoporosis	0.00165	0.00232	CcSEcCtD
Fenoldopam—Body temperature increased—Conjugated Estrogens—osteoporosis	0.00165	0.00232	CcSEcCtD
Fenoldopam—Abdominal pain—Conjugated Estrogens—osteoporosis	0.00165	0.00232	CcSEcCtD
Fenoldopam—Tachycardia—Estradiol—osteoporosis	0.00163	0.00229	CcSEcCtD
Fenoldopam—Vomiting—Ethinyl Estradiol—osteoporosis	0.00163	0.00229	CcSEcCtD
Fenoldopam—Diarrhoea—Pamidronate—osteoporosis	0.00162	0.00228	CcSEcCtD
Fenoldopam—Hyperhidrosis—Estradiol—osteoporosis	0.00161	0.00227	CcSEcCtD
Fenoldopam—Headache—Ethinyl Estradiol—osteoporosis	0.0016	0.00225	CcSEcCtD
Fenoldopam—Vomiting—Risedronate—osteoporosis	0.00158	0.00223	CcSEcCtD
Fenoldopam—Dizziness—Pamidronate—osteoporosis	0.00157	0.0022	CcSEcCtD
Fenoldopam—Headache—Risedronate—osteoporosis	0.00156	0.0022	CcSEcCtD
Fenoldopam—Nausea—Ethinyl Estradiol—osteoporosis	0.00152	0.00214	CcSEcCtD
Fenoldopam—Insomnia—Estradiol—osteoporosis	0.00151	0.00212	CcSEcCtD
Fenoldopam—Vomiting—Pamidronate—osteoporosis	0.00151	0.00212	CcSEcCtD
Fenoldopam—Dyspnoea—Estradiol—osteoporosis	0.00149	0.00209	CcSEcCtD
Fenoldopam—Headache—Pamidronate—osteoporosis	0.00148	0.00209	CcSEcCtD
Fenoldopam—Diarrhoea—Zoledronate—osteoporosis	0.00148	0.00208	CcSEcCtD
Fenoldopam—Nausea—Risedronate—osteoporosis	0.00148	0.00208	CcSEcCtD
Fenoldopam—Dizziness—Zoledronate—osteoporosis	0.00143	0.00201	CcSEcCtD
Fenoldopam—Constipation—Estradiol—osteoporosis	0.00143	0.00201	CcSEcCtD
Fenoldopam—Diarrhoea—Conjugated Estrogens—osteoporosis	0.00143	0.00201	CcSEcCtD
Fenoldopam—Nausea—Pamidronate—osteoporosis	0.00141	0.00198	CcSEcCtD
Fenoldopam—Dizziness—Conjugated Estrogens—osteoporosis	0.00138	0.00194	CcSEcCtD
Fenoldopam—Vomiting—Zoledronate—osteoporosis	0.00138	0.00194	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Estradiol—osteoporosis	0.00136	0.00192	CcSEcCtD
Fenoldopam—Headache—Zoledronate—osteoporosis	0.00136	0.00191	CcSEcCtD
Fenoldopam—Vomiting—Conjugated Estrogens—osteoporosis	0.00133	0.00186	CcSEcCtD
Fenoldopam—Abdominal pain—Estradiol—osteoporosis	0.00132	0.00185	CcSEcCtD
Fenoldopam—Body temperature increased—Estradiol—osteoporosis	0.00132	0.00185	CcSEcCtD
Fenoldopam—Headache—Conjugated Estrogens—osteoporosis	0.00131	0.00184	CcSEcCtD
Fenoldopam—Nausea—Zoledronate—osteoporosis	0.00129	0.00181	CcSEcCtD
Fenoldopam—Nausea—Conjugated Estrogens—osteoporosis	0.00124	0.00174	CcSEcCtD
Fenoldopam—Diarrhoea—Estradiol—osteoporosis	0.00114	0.00161	CcSEcCtD
Fenoldopam—Dizziness—Estradiol—osteoporosis	0.0011	0.00155	CcSEcCtD
Fenoldopam—Vomiting—Estradiol—osteoporosis	0.00106	0.00149	CcSEcCtD
Fenoldopam—Headache—Estradiol—osteoporosis	0.00105	0.00147	CcSEcCtD
Fenoldopam—Nausea—Estradiol—osteoporosis	0.000991	0.00139	CcSEcCtD
Fenoldopam—DRD1—Signaling Pathways—PSMA2—osteoporosis	0.000122	0.000422	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—PSMA5—osteoporosis	0.000122	0.000422	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—ADCY5—osteoporosis	0.000122	0.000421	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—ADCY5—osteoporosis	0.000121	0.000421	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—PSMA2—osteoporosis	0.000121	0.000419	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—PSMA5—osteoporosis	0.000121	0.000419	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—DKK1—osteoporosis	0.000121	0.000419	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—P4HB—osteoporosis	0.000121	0.000418	CbGpPWpGaD
Fenoldopam—DRD2—Circadian rythm related genes—IL6—osteoporosis	0.00012	0.000416	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—PSMA2—osteoporosis	0.00012	0.000416	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—PSMA5—osteoporosis	0.00012	0.000416	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—WNT1—osteoporosis	0.000119	0.000411	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—SPP1—osteoporosis	0.000118	0.000407	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PTH—osteoporosis	0.000117	0.000407	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—WNT1—osteoporosis	0.000117	0.000404	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—P4HB—osteoporosis	0.000116	0.000403	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—RAP1A—osteoporosis	0.000115	0.0004	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—FGA—osteoporosis	0.000115	0.000399	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—PTHLH—osteoporosis	0.000115	0.000397	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—BMP2—osteoporosis	0.000115	0.000397	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CNR2—osteoporosis	0.000114	0.000396	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—IGF1—osteoporosis	0.000114	0.000394	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—ADCY5—osteoporosis	0.000114	0.000394	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—ADCY5—osteoporosis	0.000114	0.000393	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—FGA—osteoporosis	0.000114	0.000393	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CALCA—osteoporosis	0.000113	0.000393	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PTH—osteoporosis	0.000113	0.000392	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—NFATC1—osteoporosis	0.000113	0.00039	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—FGB—osteoporosis	0.000112	0.000389	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CALCA—osteoporosis	0.000112	0.000388	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—ADCY5—osteoporosis	0.000112	0.000387	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—DKK1—osteoporosis	0.000112	0.000387	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—RAP1A—osteoporosis	0.000111	0.000385	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—POMC—osteoporosis	0.000111	0.000383	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CNR2—osteoporosis	0.00011	0.000382	CbGpPWpGaD
Fenoldopam—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	0.00011	0.00038	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—ADCY5—osteoporosis	0.000109	0.000379	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—POMC—osteoporosis	0.000109	0.000378	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—NFATC1—osteoporosis	0.000108	0.000376	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—PSMA2—osteoporosis	0.000108	0.000375	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—PSMA5—osteoporosis	0.000108	0.000375	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—P4HB—osteoporosis	0.000108	0.000374	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—DKK1—osteoporosis	0.000108	0.000373	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—WNT1—osteoporosis	0.000108	0.000372	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—PTHLH—osteoporosis	0.000107	0.000371	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—BMP2—osteoporosis	0.000107	0.000371	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—IRS2—osteoporosis	0.000106	0.000368	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—PTHLH—osteoporosis	0.000106	0.000365	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—BMP2—osteoporosis	0.000106	0.000365	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PTH—osteoporosis	0.000105	0.000364	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—FGB—osteoporosis	0.000105	0.000363	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—FGA—osteoporosis	0.000105	0.000362	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—LEP—osteoporosis	0.000104	0.00036	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—WNT1—osteoporosis	0.000104	0.000359	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—RAP1A—osteoporosis	0.000103	0.000358	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—FGB—osteoporosis	0.000103	0.000358	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—ADCY5—osteoporosis	0.000103	0.000357	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—KL—osteoporosis	0.000103	0.000357	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CNR2—osteoporosis	0.000102	0.000355	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—ADCY5—osteoporosis	0.000102	0.000352	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—KL—osteoporosis	0.000102	0.000352	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—PSMA5—osteoporosis	0.000101	0.000351	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—PSMA2—osteoporosis	0.000101	0.000351	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CALCA—osteoporosis	0.000101	0.00035	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—FGA—osteoporosis	0.000101	0.000349	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—NFATC1—osteoporosis	0.000101	0.000349	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—POMC—osteoporosis	0.000101	0.000348	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—DKK1—osteoporosis	0.0001	0.000346	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—ENO1—osteoporosis	9.99e-05	0.000346	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—PSMA2—osteoporosis	9.97e-05	0.000345	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—PSMA5—osteoporosis	9.97e-05	0.000345	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—ADCY5—osteoporosis	9.94e-05	0.000344	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—ESR1—osteoporosis	9.93e-05	0.000344	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—POMC—osteoporosis	9.92e-05	0.000343	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—POMC—osteoporosis	9.86e-05	0.000341	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PSMA5—osteoporosis	9.84e-05	0.000341	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PSMA2—osteoporosis	9.84e-05	0.000341	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—CYP19A1—osteoporosis	9.83e-05	0.00034	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—IL6R—osteoporosis	9.8e-05	0.000339	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PTHLH—osteoporosis	9.73e-05	0.000337	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—BMP2—osteoporosis	9.73e-05	0.000337	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—IL6R—osteoporosis	9.67e-05	0.000335	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—WNT1—osteoporosis	9.63e-05	0.000333	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—FGB—osteoporosis	9.52e-05	0.00033	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CALCA—osteoporosis	9.44e-05	0.000327	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PTHLH—osteoporosis	9.38e-05	0.000325	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—BMP2—osteoporosis	9.38e-05	0.000325	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—FGA—osteoporosis	9.37e-05	0.000324	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CALCA—osteoporosis	9.29e-05	0.000322	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—IRS1—osteoporosis	9.28e-05	0.000321	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—ADCY5—osteoporosis	9.24e-05	0.00032	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—POMC—osteoporosis	9.21e-05	0.000319	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PSMA5—osteoporosis	9.19e-05	0.000318	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PSMA2—osteoporosis	9.19e-05	0.000318	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—KL—osteoporosis	9.18e-05	0.000318	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—FGB—osteoporosis	9.18e-05	0.000318	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—POMC—osteoporosis	9.06e-05	0.000314	CbGpPWpGaD
Fenoldopam—ADRA2B—Hemostasis—TGFB1—osteoporosis	9e-05	0.000311	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—POMC—osteoporosis	8.95e-05	0.00031	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—POMC—osteoporosis	8.94e-05	0.000309	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PSMA2—osteoporosis	8.86e-05	0.000307	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PSMA5—osteoporosis	8.86e-05	0.000307	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—IL6R—osteoporosis	8.73e-05	0.000302	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—IL6R—osteoporosis	8.72e-05	0.000302	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PTHLH—osteoporosis	8.71e-05	0.000302	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—BMP2—osteoporosis	8.71e-05	0.000302	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—IGF1—osteoporosis	8.6e-05	0.000298	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—KL—osteoporosis	8.57e-05	0.000297	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CALCA—osteoporosis	8.57e-05	0.000297	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—FGB—osteoporosis	8.53e-05	0.000295	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—KL—osteoporosis	8.44e-05	0.000292	CbGpPWpGaD
Fenoldopam—ADRA2C—Hemostasis—TGFB1—osteoporosis	8.4e-05	0.000291	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—POMC—osteoporosis	8.36e-05	0.000289	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—POMC—osteoporosis	8.36e-05	0.000289	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CALCA—osteoporosis	8.25e-05	0.000286	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—POMC—osteoporosis	8.23e-05	0.000285	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PSMA5—osteoporosis	8.23e-05	0.000285	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PSMA2—osteoporosis	8.23e-05	0.000285	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—IL6R—osteoporosis	8.16e-05	0.000282	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—ADCY5—osteoporosis	8.07e-05	0.000279	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—POMC—osteoporosis	8.05e-05	0.000279	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—ADCY5—osteoporosis	8.03e-05	0.000278	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—IL6R—osteoporosis	8.03e-05	0.000278	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—GPX1—osteoporosis	8.01e-05	0.000277	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—CYP19A1—osteoporosis	7.99e-05	0.000276	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—ADCY5—osteoporosis	7.96e-05	0.000276	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—SPP1—osteoporosis	7.81e-05	0.00027	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—KL—osteoporosis	7.78e-05	0.000269	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—SPP1—osteoporosis	7.71e-05	0.000267	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CALCA—osteoporosis	7.67e-05	0.000265	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—POMC—osteoporosis	7.59e-05	0.000263	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—KL—osteoporosis	7.5e-05	0.000259	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—POMC—osteoporosis	7.48e-05	0.000259	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—IL6R—osteoporosis	7.4e-05	0.000256	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—MTHFR—osteoporosis	7.39e-05	0.000256	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—POMC—osteoporosis	7.31e-05	0.000253	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—ADCY5—osteoporosis	7.19e-05	0.000249	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—IL6R—osteoporosis	7.13e-05	0.000247	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—IRS2—osteoporosis	7.06e-05	0.000244	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—IRS2—osteoporosis	6.97e-05	0.000241	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—KL—osteoporosis	6.96e-05	0.000241	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—SPP1—osteoporosis	6.96e-05	0.000241	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—LEP—osteoporosis	6.91e-05	0.000239	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—TGFB1—osteoporosis	6.83e-05	0.000236	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—LEP—osteoporosis	6.82e-05	0.000236	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—POMC—osteoporosis	6.79e-05	0.000235	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—ADCY5—osteoporosis	6.72e-05	0.000232	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—IL6R—osteoporosis	6.63e-05	0.000229	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—ADCY5—osteoporosis	6.61e-05	0.000229	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—ESR1—osteoporosis	6.6e-05	0.000228	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—IL6—osteoporosis	6.57e-05	0.000228	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—ADCY5—osteoporosis	6.52e-05	0.000226	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—ESR1—osteoporosis	6.51e-05	0.000225	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—GPX1—osteoporosis	6.5e-05	0.000225	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—SPP1—osteoporosis	6.5e-05	0.000225	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—SPP1—osteoporosis	6.4e-05	0.000221	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—IRS2—osteoporosis	6.29e-05	0.000218	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—IRS1—osteoporosis	6.17e-05	0.000213	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—LEP—osteoporosis	6.16e-05	0.000213	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—ADCY5—osteoporosis	6.09e-05	0.000211	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—IRS1—osteoporosis	6.08e-05	0.000211	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—MTHFR—osteoporosis	6e-05	0.000208	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—POMC—osteoporosis	5.94e-05	0.000206	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—POMC—osteoporosis	5.91e-05	0.000205	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—SPP1—osteoporosis	5.9e-05	0.000204	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—ESR1—osteoporosis	5.88e-05	0.000203	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—IRS2—osteoporosis	5.88e-05	0.000203	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—ADCY5—osteoporosis	5.87e-05	0.000203	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—POMC—osteoporosis	5.86e-05	0.000203	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—IL6R—osteoporosis	5.79e-05	0.0002	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—IRS2—osteoporosis	5.78e-05	0.0002	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—LEP—osteoporosis	5.75e-05	0.000199	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—IL6R—osteoporosis	5.71e-05	0.000198	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—IGF1—osteoporosis	5.71e-05	0.000198	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—SPP1—osteoporosis	5.68e-05	0.000197	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—LEP—osteoporosis	5.66e-05	0.000196	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—IGF1—osteoporosis	5.63e-05	0.000195	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—IRS1—osteoporosis	5.49e-05	0.00019	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—ESR1—osteoporosis	5.49e-05	0.00019	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—ADCY5—osteoporosis	5.46e-05	0.000189	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—ESR1—osteoporosis	5.4e-05	0.000187	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—IRS2—osteoporosis	5.33e-05	0.000185	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—POMC—osteoporosis	5.29e-05	0.000183	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—SPP1—osteoporosis	5.28e-05	0.000183	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—LEP—osteoporosis	5.22e-05	0.000181	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—MYC—osteoporosis	5.17e-05	0.000179	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—IL6R—osteoporosis	5.16e-05	0.000179	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—TGFB1—osteoporosis	5.15e-05	0.000178	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—IRS2—osteoporosis	5.14e-05	0.000178	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—IRS1—osteoporosis	5.13e-05	0.000178	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—IGF1—osteoporosis	5.09e-05	0.000176	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—IRS1—osteoporosis	5.05e-05	0.000175	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—LEP—osteoporosis	5.03e-05	0.000174	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—ESR1—osteoporosis	4.98e-05	0.000172	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—POMC—osteoporosis	4.94e-05	0.000171	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—POMC—osteoporosis	4.86e-05	0.000168	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—IL6R—osteoporosis	4.82e-05	0.000167	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—ESR1—osteoporosis	4.8e-05	0.000166	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—POMC—osteoporosis	4.8e-05	0.000166	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IRS2—osteoporosis	4.77e-05	0.000165	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—IGF1—osteoporosis	4.75e-05	0.000164	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—IL6R—osteoporosis	4.74e-05	0.000164	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—IGF1—osteoporosis	4.68e-05	0.000162	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—LEP—osteoporosis	4.67e-05	0.000162	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—IRS1—osteoporosis	4.66e-05	0.000161	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—IRS1—osteoporosis	4.48e-05	0.000155	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—POMC—osteoporosis	4.48e-05	0.000155	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—ESR1—osteoporosis	4.46e-05	0.000154	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—IL6R—osteoporosis	4.37e-05	0.000151	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—IL6—osteoporosis	4.37e-05	0.000151	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—POMC—osteoporosis	4.32e-05	0.000149	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—IGF1—osteoporosis	4.31e-05	0.000149	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—IL6—osteoporosis	4.31e-05	0.000149	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—IL6R—osteoporosis	4.21e-05	0.000146	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IRS1—osteoporosis	4.17e-05	0.000144	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—IGF1—osteoporosis	4.15e-05	0.000144	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—POMC—osteoporosis	4.01e-05	0.000139	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IL6R—osteoporosis	3.91e-05	0.000135	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—IL6—osteoporosis	3.89e-05	0.000135	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—IL6—osteoporosis	3.88e-05	0.000134	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IGF1—osteoporosis	3.86e-05	0.000134	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—IL6—osteoporosis	3.63e-05	0.000126	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—IL6—osteoporosis	3.58e-05	0.000124	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—MYC—osteoporosis	3.43e-05	0.000119	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—TGFB1—osteoporosis	3.42e-05	0.000119	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—MYC—osteoporosis	3.39e-05	0.000117	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—TGFB1—osteoporosis	3.38e-05	0.000117	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—IL6—osteoporosis	3.3e-05	0.000114	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—IL6—osteoporosis	3.18e-05	0.00011	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MYC—osteoporosis	3.06e-05	0.000106	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—TGFB1—osteoporosis	3.05e-05	0.000106	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—IL6—osteoporosis	2.95e-05	0.000102	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MYC—osteoporosis	2.86e-05	9.89e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—TGFB1—osteoporosis	2.85e-05	9.86e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MYC—osteoporosis	2.81e-05	9.73e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—TGFB1—osteoporosis	2.8e-05	9.71e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MYC—osteoporosis	2.59e-05	8.97e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—TGFB1—osteoporosis	2.59e-05	8.95e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—IL6—osteoporosis	2.58e-05	8.93e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—IL6—osteoporosis	2.55e-05	8.81e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MYC—osteoporosis	2.5e-05	8.64e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—TGFB1—osteoporosis	2.49e-05	8.62e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MYC—osteoporosis	2.32e-05	8.03e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—TGFB1—osteoporosis	2.31e-05	8.01e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—IL6—osteoporosis	2.3e-05	7.96e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—IL6—osteoporosis	2.15e-05	7.43e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—IL6—osteoporosis	2.11e-05	7.31e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—IL6—osteoporosis	1.95e-05	6.74e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—IL6—osteoporosis	1.88e-05	6.5e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IL6—osteoporosis	1.74e-05	6.04e-05	CbGpPWpGaD
